NIH's Role In Sustaining the U.S. Economy 2021 Update Now Available here
UMR Urges House and Senate Leaders to Include NIH Funding in COVID Relief Package read here
UMR releases new fact sheets on COVID-19 and biomedical research. Read here
See how UMR members are aiding in the fight against the coronavirus here
A new episode of the Amazing Things Podcast is now available! Check it out here.

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Despite Spreading Easily, Delta Is Uniquely Weak Against Covid-19 Antibodies, Study Finds

Despite the emergence of delta as the dominant variant of Covid-19 in the U.S., nearly all of the antibodies produced by the Pfizer vaccine are able to neutralize it, according to a study published Monday, underscoring the protection offered by vaccinations in a pandemic where nearly all cases—and virtually all serious cases—are among the unvaccinated.

“In face of vaccination, delta is relatively a wimpy virus,” said Ali Ellebedy, a senior co-author of the study and a professor of pathology and immunology at Washington University School of Medicine in St. Louis, in a press release announcing the study. “If we had a variant that was more resistant like beta but spread as easily as delta, we’d be in more trouble.”